consideration calculated from the Company’s reviewed consolidated financial statements for the period ended 30 September 2017 in which the Company has no asset- disposing transactions over the past six months
:- Financial Position As at 30 September 2020, total consolidated assets of the Company and its subsidiary reduced by 56.45 million baht or 1.92% compare to the previous year, which was a decrease from current
the consolidated financial statements of the Company and its subsidiaries for the first quarter ended 31st March 2020. The Company reported a consolidated loss (attributable to equity holders of the
financial statements, including the consolidated financial statements of the Company and its subsidiaries for the third quarter and nine month period ended 30th September 2019. The Company reported
results of the Company and its subsidiaries for of the second quarter of the year 2019, ended 30 June 2019 as follows: Statement of comprehensive income Statement of comprehensive income Consolidated
related corporate tax transaction, the normalized net profit would be approximately THB 97.42 million or a surge of 48% yoy. Page 3 of 4 Statement of Financial Position as of March 31, 2019 The consolidated
increased significantly by 19. 4% yoy with the margin improved from 17.4% to 19.2%. Page 3 of 4 Statement of Financial Position as of September 30, 2019 The consolidated total assets as of 30 September 2019
consolidated financial statement of the Company and its subsidiaries ended 31 March 2017, the net tangible asset value of the Company shows deficits. Transaction size is Baht 46,671,875.94 which is not exceed
Exchange of Thailand The Board of Directors Meeting of Wattanapat Hospital Trang Public Company Limited (the “Company”) No. 3/2017, held on February 26, 2017, approving the audited consolidated financial
Company's Net Tangible Asset Value as per the consolidated financial statements ended as at 31st March 2020, it is a medium sized transaction requiring the Company to: (a) take the approval of the Board of